The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.12016-12017 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 12017 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 12016 |
| container_title | Blood |
| container_volume | 140 |
| creator | Vassilakopoulos, Theodoros P. Arapaki, Maria Panagiota Diamantopoulos, Panagiotis T Angelopoulou, Maria K. Nadali, Gianpaolo Tsourouflis, Gerasimos Moschogiannis, Maria Dimopoulou, Maria Siakantaris, Marina Yiakoumis, Xanthi Kontopidou, Flora Kalpadakis, Christina H. Gainaru, Gabriela Asimakopoulos, John V. Dimou, Maria Sachanas, Sotirios Kyrtsonis, Marie-Christine Tsaftaridis, Panayiotis Plata, Eleni Variami, Eleni Viniou, Nora-Athina Pizzolo, Giovanni Sarris, Andreas H. Konstantopoulos, Kostas Panayiotidis, Panayiotis Pangalis, Gerassimos |
| description | |
| doi_str_mv | 10.1182/blood-2022-169972 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_169972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122070409</els_id><sourcerecordid>S0006497122070409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1852-ee80dcdd4b993a43b43eaead4ccbdef13219092a627f28346630bb5e70191cea3</originalsourceid><addsrcrecordid>eNp9kc2O0zAUhQMCiTLwACyQ7rJdhLGdnzaw6mSmFClVR5rANnLsm8aQxB3bKcpr8SA8Ey4diR0bW7o-39XxOUHwjpIPlK7Ydd1pLUNGGAtpmmVL9jyY0YStQkIYeRHMCCFpGGdL-ip4be13QmgcsWT27H3ZItwbfRi0dUrAgzoMqlGCDwJBN_CAZuzhBh0PGeyU8MpO12OnBpjb379Yv4ACT9hZ8JN77hQOzsJP5VrYann44afF1B9b3XOYb4vFR9iogXew9sdklQU9QEaTf2hpkDuUlxXrm2-3oA3cPY7qxDsvgPl5ho8LyFvstWvR8ON01uS6r9XgyZ2WvFNugvLpcZ6X1_muXMBGi9Gq4QBOgyfhFh2a3vtxytvwv90fneq9u3x04b5p7JvgZcM7i2-f7qvg6-auzLdhsf_8JV8XoaCrhIWIKyKFlHGdZRGPozqOkCOXsRC1xIZGjGYkYzxly4atojhNI1LXCS4JzahAHl0F9LLX52utwaY6Gm_ETBUl1bnf6m-_1bnf6tKvZz5dGB8-nhSaygofoUCpDApXSa3-Q_8Bq_Cw3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Vassilakopoulos, Theodoros P. ; Arapaki, Maria Panagiota ; Diamantopoulos, Panagiotis T ; Angelopoulou, Maria K. ; Nadali, Gianpaolo ; Tsourouflis, Gerasimos ; Moschogiannis, Maria ; Dimopoulou, Maria ; Siakantaris, Marina ; Yiakoumis, Xanthi ; Kontopidou, Flora ; Kalpadakis, Christina H. ; Gainaru, Gabriela ; Asimakopoulos, John V. ; Dimou, Maria ; Sachanas, Sotirios ; Kyrtsonis, Marie-Christine ; Tsaftaridis, Panayiotis ; Plata, Eleni ; Variami, Eleni ; Viniou, Nora-Athina ; Pizzolo, Giovanni ; Sarris, Andreas H. ; Konstantopoulos, Kostas ; Panayiotidis, Panayiotis ; Pangalis, Gerassimos</creator><creatorcontrib>Vassilakopoulos, Theodoros P. ; Arapaki, Maria Panagiota ; Diamantopoulos, Panagiotis T ; Angelopoulou, Maria K. ; Nadali, Gianpaolo ; Tsourouflis, Gerasimos ; Moschogiannis, Maria ; Dimopoulou, Maria ; Siakantaris, Marina ; Yiakoumis, Xanthi ; Kontopidou, Flora ; Kalpadakis, Christina H. ; Gainaru, Gabriela ; Asimakopoulos, John V. ; Dimou, Maria ; Sachanas, Sotirios ; Kyrtsonis, Marie-Christine ; Tsaftaridis, Panayiotis ; Plata, Eleni ; Variami, Eleni ; Viniou, Nora-Athina ; Pizzolo, Giovanni ; Sarris, Andreas H. ; Konstantopoulos, Kostas ; Panayiotidis, Panayiotis ; Pangalis, Gerassimos</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-169972</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.12016-12017</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1852-ee80dcdd4b993a43b43eaead4ccbdef13219092a627f28346630bb5e70191cea3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Vassilakopoulos, Theodoros P.</creatorcontrib><creatorcontrib>Arapaki, Maria Panagiota</creatorcontrib><creatorcontrib>Diamantopoulos, Panagiotis T</creatorcontrib><creatorcontrib>Angelopoulou, Maria K.</creatorcontrib><creatorcontrib>Nadali, Gianpaolo</creatorcontrib><creatorcontrib>Tsourouflis, Gerasimos</creatorcontrib><creatorcontrib>Moschogiannis, Maria</creatorcontrib><creatorcontrib>Dimopoulou, Maria</creatorcontrib><creatorcontrib>Siakantaris, Marina</creatorcontrib><creatorcontrib>Yiakoumis, Xanthi</creatorcontrib><creatorcontrib>Kontopidou, Flora</creatorcontrib><creatorcontrib>Kalpadakis, Christina H.</creatorcontrib><creatorcontrib>Gainaru, Gabriela</creatorcontrib><creatorcontrib>Asimakopoulos, John V.</creatorcontrib><creatorcontrib>Dimou, Maria</creatorcontrib><creatorcontrib>Sachanas, Sotirios</creatorcontrib><creatorcontrib>Kyrtsonis, Marie-Christine</creatorcontrib><creatorcontrib>Tsaftaridis, Panayiotis</creatorcontrib><creatorcontrib>Plata, Eleni</creatorcontrib><creatorcontrib>Variami, Eleni</creatorcontrib><creatorcontrib>Viniou, Nora-Athina</creatorcontrib><creatorcontrib>Pizzolo, Giovanni</creatorcontrib><creatorcontrib>Sarris, Andreas H.</creatorcontrib><creatorcontrib>Konstantopoulos, Kostas</creatorcontrib><creatorcontrib>Panayiotidis, Panayiotis</creatorcontrib><creatorcontrib>Pangalis, Gerassimos</creatorcontrib><title>The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kc2O0zAUhQMCiTLwACyQ7rJdhLGdnzaw6mSmFClVR5rANnLsm8aQxB3bKcpr8SA8Ey4diR0bW7o-39XxOUHwjpIPlK7Ydd1pLUNGGAtpmmVL9jyY0YStQkIYeRHMCCFpGGdL-ip4be13QmgcsWT27H3ZItwbfRi0dUrAgzoMqlGCDwJBN_CAZuzhBh0PGeyU8MpO12OnBpjb379Yv4ACT9hZ8JN77hQOzsJP5VrYann44afF1B9b3XOYb4vFR9iogXew9sdklQU9QEaTf2hpkDuUlxXrm2-3oA3cPY7qxDsvgPl5ho8LyFvstWvR8ON01uS6r9XgyZ2WvFNugvLpcZ6X1_muXMBGi9Gq4QBOgyfhFh2a3vtxytvwv90fneq9u3x04b5p7JvgZcM7i2-f7qvg6-auzLdhsf_8JV8XoaCrhIWIKyKFlHGdZRGPozqOkCOXsRC1xIZGjGYkYzxly4atojhNI1LXCS4JzahAHl0F9LLX52utwaY6Gm_ETBUl1bnf6m-_1bnf6tKvZz5dGB8-nhSaygofoUCpDApXSa3-Q_8Bq_Cw3Q</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Vassilakopoulos, Theodoros P.</creator><creator>Arapaki, Maria Panagiota</creator><creator>Diamantopoulos, Panagiotis T</creator><creator>Angelopoulou, Maria K.</creator><creator>Nadali, Gianpaolo</creator><creator>Tsourouflis, Gerasimos</creator><creator>Moschogiannis, Maria</creator><creator>Dimopoulou, Maria</creator><creator>Siakantaris, Marina</creator><creator>Yiakoumis, Xanthi</creator><creator>Kontopidou, Flora</creator><creator>Kalpadakis, Christina H.</creator><creator>Gainaru, Gabriela</creator><creator>Asimakopoulos, John V.</creator><creator>Dimou, Maria</creator><creator>Sachanas, Sotirios</creator><creator>Kyrtsonis, Marie-Christine</creator><creator>Tsaftaridis, Panayiotis</creator><creator>Plata, Eleni</creator><creator>Variami, Eleni</creator><creator>Viniou, Nora-Athina</creator><creator>Pizzolo, Giovanni</creator><creator>Sarris, Andreas H.</creator><creator>Konstantopoulos, Kostas</creator><creator>Panayiotidis, Panayiotis</creator><creator>Pangalis, Gerassimos</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs</title><author>Vassilakopoulos, Theodoros P. ; Arapaki, Maria Panagiota ; Diamantopoulos, Panagiotis T ; Angelopoulou, Maria K. ; Nadali, Gianpaolo ; Tsourouflis, Gerasimos ; Moschogiannis, Maria ; Dimopoulou, Maria ; Siakantaris, Marina ; Yiakoumis, Xanthi ; Kontopidou, Flora ; Kalpadakis, Christina H. ; Gainaru, Gabriela ; Asimakopoulos, John V. ; Dimou, Maria ; Sachanas, Sotirios ; Kyrtsonis, Marie-Christine ; Tsaftaridis, Panayiotis ; Plata, Eleni ; Variami, Eleni ; Viniou, Nora-Athina ; Pizzolo, Giovanni ; Sarris, Andreas H. ; Konstantopoulos, Kostas ; Panayiotidis, Panayiotis ; Pangalis, Gerassimos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1852-ee80dcdd4b993a43b43eaead4ccbdef13219092a627f28346630bb5e70191cea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vassilakopoulos, Theodoros P.</creatorcontrib><creatorcontrib>Arapaki, Maria Panagiota</creatorcontrib><creatorcontrib>Diamantopoulos, Panagiotis T</creatorcontrib><creatorcontrib>Angelopoulou, Maria K.</creatorcontrib><creatorcontrib>Nadali, Gianpaolo</creatorcontrib><creatorcontrib>Tsourouflis, Gerasimos</creatorcontrib><creatorcontrib>Moschogiannis, Maria</creatorcontrib><creatorcontrib>Dimopoulou, Maria</creatorcontrib><creatorcontrib>Siakantaris, Marina</creatorcontrib><creatorcontrib>Yiakoumis, Xanthi</creatorcontrib><creatorcontrib>Kontopidou, Flora</creatorcontrib><creatorcontrib>Kalpadakis, Christina H.</creatorcontrib><creatorcontrib>Gainaru, Gabriela</creatorcontrib><creatorcontrib>Asimakopoulos, John V.</creatorcontrib><creatorcontrib>Dimou, Maria</creatorcontrib><creatorcontrib>Sachanas, Sotirios</creatorcontrib><creatorcontrib>Kyrtsonis, Marie-Christine</creatorcontrib><creatorcontrib>Tsaftaridis, Panayiotis</creatorcontrib><creatorcontrib>Plata, Eleni</creatorcontrib><creatorcontrib>Variami, Eleni</creatorcontrib><creatorcontrib>Viniou, Nora-Athina</creatorcontrib><creatorcontrib>Pizzolo, Giovanni</creatorcontrib><creatorcontrib>Sarris, Andreas H.</creatorcontrib><creatorcontrib>Konstantopoulos, Kostas</creatorcontrib><creatorcontrib>Panayiotidis, Panayiotis</creatorcontrib><creatorcontrib>Pangalis, Gerassimos</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vassilakopoulos, Theodoros P.</au><au>Arapaki, Maria Panagiota</au><au>Diamantopoulos, Panagiotis T</au><au>Angelopoulou, Maria K.</au><au>Nadali, Gianpaolo</au><au>Tsourouflis, Gerasimos</au><au>Moschogiannis, Maria</au><au>Dimopoulou, Maria</au><au>Siakantaris, Marina</au><au>Yiakoumis, Xanthi</au><au>Kontopidou, Flora</au><au>Kalpadakis, Christina H.</au><au>Gainaru, Gabriela</au><au>Asimakopoulos, John V.</au><au>Dimou, Maria</au><au>Sachanas, Sotirios</au><au>Kyrtsonis, Marie-Christine</au><au>Tsaftaridis, Panayiotis</au><au>Plata, Eleni</au><au>Variami, Eleni</au><au>Viniou, Nora-Athina</au><au>Pizzolo, Giovanni</au><au>Sarris, Andreas H.</au><au>Konstantopoulos, Kostas</au><au>Panayiotidis, Panayiotis</au><au>Pangalis, Gerassimos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>12016</spage><epage>12017</epage><pages>12016-12017</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-169972</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.12016-12017 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_169972 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | The Prognostic Significance of Serum Beta-2 Microglobulin (sβ2m) Levels in Patients with Hodgkin Lymphoma (HL): Final Analysis on 915 Patients Treated with ABVD or Equivalent (ABVDeq) Chemotherapy or Combined Modality Therapy (CT/CMT) Focusing to the Determination of Optimal Cut-Offs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A44%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Prognostic%20Significance%20of%20Serum%20Beta-2%20Microglobulin%20(s%CE%B22m)%20Levels%20in%20Patients%20with%20Hodgkin%20Lymphoma%20(HL):%20Final%20Analysis%20on%20915%20Patients%20Treated%20with%20ABVD%20or%20Equivalent%20(ABVDeq)%20Chemotherapy%20or%20Combined%20Modality%20Therapy%20(CT/CMT)%20Focusing%20to%20the%20Determination%20of%20Optimal%20Cut-Offs&rft.jtitle=Blood&rft.au=Vassilakopoulos,%20Theodoros%20P.&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=12016&rft.epage=12017&rft.pages=12016-12017&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-169972&rft_dat=%3Celsevier_cross%3ES0006497122070409%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122070409&rfr_iscdi=true |